Ohm Oncology competitorsClear all

Ohm Oncology's top competitors include Blueprint Medicines, Achilles Therapeutics, BeiGene and BioNTech.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Ohm Oncology
Ohm Oncology
Ohm Oncology is a drug development company committed to treating drug-resistant neoplasms and cancers with multi-mechanism compounds.
Blueprint Medicines
Blueprint Medicines
Blueprint Medicines discovers and develops highly selective kinase inhibitors for patients with genomically defined cancers.
Achilles Therapeutics
Achilles Therapeutics
Achilles Therapeutics is a developer of immunotherapies intended to offer therapies to treat cancer.
BeiGene
BeiGene
BeiGene is a life science biotechnology company.
BioNTech
BioNTech
BioNTech is biopharmaceutical company pioneering the development of individualized therapies for cancer and other diseases.
Founding Date
Founding Date
2015
Founding Date
2011
Founding Date
2016
Founding Date
2010
Founding Date
2008
Type
Type
Private
Type
Public
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
Austin, US HQ
Locations
Cambridge, US HQ
Zug, CH
Cambridge, US
Locations
London, GB HQ
Stevenage, GB
Locations
Changping Qu, CN HQ
Guangzhou Shi, CN
Suzhou Shi, CN
Basel, CH
Basel, CH
see more
Locations
Mainz, DE HQ
Halle (Saale), DE
Idar Oberstein, DE
Marburg, DE
Neuried, DE
Planegg, DE
Cambridge, US
see more
Employees
Employees
167% decrease
Employees
38376% increase
Employees
153
Employees
5,4002% increase
Employees
1,30018% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
5.8 b
Valuation ($)
N/A
Valuation ($)
31.1 b
Valuation ($)
90 b
Twitter followers
Twitter followers
N/A
Twitter followers
2.2 k
Twitter followers
335
Twitter followers
N/A
Twitter followers
66.8 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
13
Number of tweets (last 30 days)
3
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
4
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
5.2
Average likes per tweet (last 30 days)
1
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
335.3
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
33.33%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Alexa Website Rank
Alexa Website Rank
N/A
Alexa Website Rank
311593
Alexa Website Rank
333221
Alexa Website Rank
277917
Alexa Website Rank
252303
Employee Rating
Employee Rating
N/A
Employee Rating
3.7
Employee Rating
3.8
Employee Rating
2.9
Employee Rating
4

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$793.7m (FY, 2020)
Revenue (est.)
N/A
Revenue (est.)
$308.9m (FY, 2020)
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
$425k (FY, 2020)
Cost of goods
N/A
Cost of goods
$70.7m (FY, 2020)
Cost of goods
€59.3m (FY, 2020)
Gross profit
Gross profit
N/A
Gross profit
$793.3m (FY, 2020)
Gross profit
N/A
Gross profit
$238.2m (FY, 2020)
Gross profit
N/A
Net income
Net income
N/A
Net income
$313.9m (FY, 2020)
Net income
($33.2m) (FY, 2020)
Net income
($1.6b) (FY, 2020)
Net income
€15.2m (FY, 2020)

Operating

Trademarks (US)
Trademarks (US)
N/A
Trademarks (US)
N/A
Trademarks (US)
3 (May, 2021)
Trademarks (US)
N/A
Trademarks (US)
8 (Oct, 2019)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 115m
Total funding raised
$ 138.1m
Total funding raised
$ 75m
Total funding raised
$ 1.4b
For sources of this data, please see the company profile

View company profiles

Blueprint Medicines
HQ
Cambridge, US
Employees
383

Blueprint Medicines discovers and develops highly selective kinase inhibitors for patients with genomically defined cancers.

View company
Achilles Therapeutics
HQ
London, GB
Employees
153

Achilles Therapeutics is a developer of immunotherapies intended to offer therapies to treat cancer.

View company
BeiGene
HQ
Changping Qu, CN
Employees
5,400↑ 2% increase

BeiGene is a life science biotechnology company.

View company
BioNTech
HQ
Mainz, DE
Employees
1,300↑ 18% increase

BioNTech is biopharmaceutical company pioneering the development of individualized therapies for cancer and other diseases.

View company